In addition to other important glycan antigens, a number of glycan structures (both N- and O-linked) were described that carry the (s)Lex/a antigen, which has profound implications in chemoresistance, metastasis, and immunomodulation in AML, and is currently of high interest with several clinical trials registered. Here, FUT4 is linked to acute myeloid leukemia.